Related Experiment Video
Updated: May 24, 2025
05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.1K
Investigating Local Sequence-Structural Attributes of Amyloidogenic Light Chain Variable Domains
Puneet Rawat1,2, R Prabakaran2,3, Divya Sharma2
1University of Oslo and Oslo University Hospital, Oslo, Norway.
Proteins
|March 4, 2025
Summary
Researchers identified specific protein regions and gatekeeper residues that predict amyloid formation in antibody light chains, crucial for understanding light chain amyloidosis and designing new therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Light chain amyloidosis results from misfolded antibody light chains forming amyloid fibrils, leading to organ damage.
- Predicting protein aggregation (amyloidogenesis) remains challenging despite understanding contributing factors.
Purpose of the Study:
- To analyze antibody light chain sequences for factors influencing amyloid formation.
- To identify structural features distinguishing amyloidogenic from non-amyloidogenic light chains.
Main Methods:
- Analyzed 1828 antibody light chain variable region (VL) sequences from the AL-Base database.
- Evaluated physicochemical properties and solvent-exposed aggregation-prone regions (APRs).
- Identified and analyzed structural gatekeeper residues near APRs using specific solvent-accessible surface area (rASA) and distance cutoffs.
Main Results:
- Physicochemical properties showed no consistent link to aggregation.
- Amyloidogenic light chains had more frequent solvent-exposed APRs (2-15% difference) at optimal rASA cutoffs.
- Non-amyloidogenic light chains more often possessed gatekeeper residues near APRs.
- Lambda light chains showed more APRs and fewer gatekeepers, increasing aggregation risk.
Conclusions:
- Solvent-exposed APRs and the presence/absence of gatekeeper residues are key predictors of light chain amyloidogenicity.
- Optimal rASA cutoff is 35% for APRs and 4Å for gatekeeper residue identification.
- Findings advance understanding of light chain amyloidosis pathogenesis and therapeutic antibody design.
Related Concept Videos
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
01:10Antibody Structure
58.7K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.7K
02:26Conservation of Protein Domains Over Different Proteins
10.7K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
10.7K
01:49Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
01:25Antibody Structure and Classes
732
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
732
01:22Protein Folding
117.0K
Overview
117.0K